Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Lupin launches generic drug to treat depression in US

      Lupin launches generic drug to treat depression in US

      supriya kashyap kashyap4 March 2017 11:30 AM IST
      Mumbai : Pharma major Lupin Ltd announced the launch of generic drug Pristiq (Desvenlafaxine Succinate) to treat depression in the US market."We have...
      Health Vectors Wins Digital Health Competition at 2017 HITLAB Innovators Summit: India

      Health Vectors Wins Digital Health Competition at 2017 HITLAB Innovators Summit: India

      supriya kashyap kashyap4 March 2017 11:27 AM IST
      New Delhi : Developers of my health vectors were named grand prize winners of the 2017 HITLAB World Cup: India, a digital health tech challenge open...
      Merck KGaA, Pfizer get priority review for bladder cancer drug

      Merck KGaA, Pfizer get priority review for bladder cancer drug

      supriya kashyap kashyap3 March 2017 10:10 AM IST
      German drugmaker Merck KGaA and U.S. partner Pfizer have been granted priority review status in the United States as they seek to widen the use of...
      FDA approves Odactra for house dust mite allergies

      FDA approves Odactra for house dust mite allergies

      supriya kashyap kashyap3 March 2017 10:10 AM IST
      The U.S. Food and Drug Administration approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house...
      Sun Pharma Announces Data from Tildrakizumab Clinical Development Program to be Presented at the 2017 American Academy of Dermatology Meeting

      Sun Pharma Announces Data from Tildrakizumab Clinical Development Program to be Presented at the 2017 American Academy of Dermatology Meeting

      supriya kashyap kashyap3 March 2017 10:09 AM IST
      Mumbai : Sun Pharmaceutical Industries Ltd announced that several new analyses from Phase-1 and the pivotal Phase-3 clinical trials (reSURFACE 1 and...
      Lupin launches cream in US to treat skin inflammation

      Lupin launches cream in US to treat skin inflammation

      supriya kashyap kashyap2 March 2017 10:42 AM IST
      New Delhi : Drug firm Lupin has launched in the American market its Clobetasol Propionate topical solution used for providing relief in various skin...
      Healthcare sector may grow by 12-14 percent over next 5 years: ICRA

      Healthcare sector may grow by 12-14 percent over next 5 years: ICRA

      supriya kashyap kashyap2 March 2017 10:41 AM IST
      Mumbai : The health care sector is expected to witness an annual revenue growth of 12-14 per cent over the next five years due increasing medical...
      USFDA issues warning letter to Wockhardts US arm

      USFDA issues warning letter to Wockhardt's US arm

      supriya kashyap kashyap2 March 2017 10:41 AM IST
      New Delhi : Drug firm Wockhardt said the US health regulator has issued a warning letter to its step down subsidiary Morton Grove Pharmaceuticals...
      Trump idea to expand healthcare competition faces hurdles

      Trump idea to expand healthcare competition faces hurdles

      supriya kashyap kashyap2 March 2017 10:40 AM IST
      Calif. : Allowing insurers to market health care policies across state lines is one of President Donald Trump's main ideas for bringing down...
      Sanofi and Lonza to build new $285 mln Swiss biologics facility

      Sanofi and Lonza to build new $285 mln Swiss biologics facility

      supriya kashyap kashyap1 March 2017 10:50 AM IST
      Paris : French drug maker Sanofi and Swiss manufacturer Lonza will invest 270 million euros ($285 million) in a new large-scale biologics facility...
      India needs regulatory body for medical devices: Kiran Mazumdar-Shaw

      India needs regulatory body for medical devices: Kiran Mazumdar-Shaw

      supriya kashyap kashyap1 March 2017 10:49 AM IST
      Hyderabad : Biotech entrepreneur Kiran Mazumdar-Shaw has called for establishing a standard-setting regulatory body for medical devices, as...
      FDA to expedite review of Teva drug for movement disorder

      FDA to expedite review of Teva drug for movement disorder

      supriya kashyap kashyap1 March 2017 10:49 AM IST
      TEL AVIV : Israel-based Teva Pharmaceutical Industries said the U.S. Food and Drug Administration (FDA) has granted "priority review" for its SD-809...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok